Alan Sandler, MD

Genentech, a leading biotechnology company, is dedicated to bringing personalized cancer immunotherapy to patients, which means each person would have a treatment tailored to harness their own immune system to fight cancer. Scientists are studying atezolizumab (pronounced "a-tez-o-liz-u-mab") in multiple cancer types including lung, kidney, breast and bladder cancers.
In fact, Genentech just announced findings that atezolizumab shrank tumors in people with a certain type of advanced lung cancer. These data are important because it is estimated that 60 percent of lung cancer diagnoses in the United States are made when the disease is in the advanced stages. Immunotherapy is the latest advancement in cancer treatment; a topic I know is of interest to your readers.  Alan Sandler, MD joins Lisa to chat about this.

Hits 1406
« Rajiv Sharma, MD MD Medicine Shows Dr David Agus Author of The Lucky Years »

Search The IYH Website

Healthy Reads

Lisa Davis's Blog

My interview with filmmaker Joe Cross, an extraordinary entrepreneur, author and...
From Laura Prepon, star of Orange Is the New Black, and integrative nutritionist...
Lisa Davis interviews Dr. Mark Menolascino of the MENO CLINIC CENTER FOR ADVANCE...